BRIEF-Novartis Wins Positive CHMP Opinion For Gilenya For MS In Children

1 分钟阅读

Sept 21 (Reuters) - Novartis AG:

* NOVARTIS RECEIVES POSITIVE CHMP OPINION FOR GILENYA® FOR THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH MS, MARKING A MAJOR MEDICAL ADVANCE FOR YOUNG MS PATIENTS IN EUROPE Source text for Eikon: Further company coverage: